Sarcopenia

SARCOPENIA An in-depth examination of sarcopenia’s underexplored yet widespread impact within the field of gerontology Sarcopenia is common in older men and women, and yet awareness of its clinical relevance is still relatively low. Only formally included in the International Classification of Diseases in 2016, the condition may impact societies with serious health-related and financial consequences unless consistent, effective methods of identification and management are adopted. This second edition of Sarcopenia provides geriatricians and other healthcare professionals with a revised and expanded examination of this understudied and underdiagnosed condition. Edited by two leading authorities on the subject, it covers the epidemiology and diagnosis of sarcopenia, as well as treatment options and possible prevention strategies. Eight newly written chapters build upon existing knowledge with fresh data on topics including sarcopenia’s biomarkers and its impact on the healthcare economy. This important text: Defines sarcopenia and explains its clinical relevance Covers all recent scientific evidence Outlines treatment options Considers prevention strategies Discusses sarcopenia as a public health priority Features eight new chapters covering topics such as sarcopenia’s clinical management, its biomarkers, and its financial impact Containing vital information for clinicians and other professionals working in geriatric care, nursing homes, nutrition, cancer, endocrinology, surgery, sports medicine and many other specialties, Sarcopenia, second edition, is a groundbreaking and essential new resource.

Produk Detail:

  • Author : Alfonso J. Cruz-Jentoft
  • Publisher : John Wiley & Sons
  • Pages : 464 pages
  • ISBN : 1119597870
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKSarcopenia

Sarcopenia

Sarcopenia
  • Author : Alfonso J. Cruz-Jentoft,John E. Morley
  • Publisher : John Wiley & Sons
  • Release : 06 July 2021
GET THIS BOOKSarcopenia

SARCOPENIA An in-depth examination of sarcopenia’s underexplored yet widespread impact within the field of gerontology Sarcopenia is common in older men and women, and yet awareness of its clinical relevance is still relatively low. Only formally included in the International Classification of Diseases in 2016, the condition may impact societies with serious health-related and financial consequences unless consistent, effective methods of identification and management are adopted. This second edition of Sarcopenia provides geriatricians and other healthcare professionals with a revised

Sarcopenia

Sarcopenia
  • Author : Dominique Meynial-Denis
  • Publisher : CRC Press
  • Release : 30 August 2019
GET THIS BOOKSarcopenia

Sarcopenia: Molecular, Cellular, and Nutritional Aspects describes the progressive loss of skeletal muscle mass and strength, defined by Rosenberg in 1997 as a hallmark of aging and referred to as “sarcopenia.” As life expectancy continues to increase worldwide, sarcopenia has become a major public health issue. The condition worsens in the presence of chronic diseases accelerating its progression. Sarcopenia is not considered to be “a process of normative aging” but according to the International Classification of Disease, Tenth Revision, Clinical Modification (

Frailty and Sarcopenia

Frailty and Sarcopenia
  • Author : Yannis Dionyssiotis
  • Publisher : BoD – Books on Demand
  • Release : 30 August 2017
GET THIS BOOKFrailty and Sarcopenia

Frailty is considered a multisystem impairment that makes an individual vulnerable to external or internal stressors. Sarcopenia, the age-dependent loss of muscle mass and function, is proposed as the biological substrate and the pathway whereby the consequences of physical frailty develop. These syndromes are associated with a negative impact in quality of life and can lead to the occurrence of disability, institutionalization, and even mortality. The book focuses upon all the related aspects of frailty and sarcopenia and the new

Clinical Nutrition and Aging

Clinical Nutrition and Aging
  • Author : Chad Cox
  • Publisher : CRC Press
  • Release : 02 October 2017
GET THIS BOOKClinical Nutrition and Aging

This title includes a number of Open Access chapters. Sarcopenia—the loss of muscle mass and strength that occurs with advancing age—is a major health challenge, particularly in North America, Europe, and Japan, which have large aging populations. This compendium volume is a valuable addition to the existing literature, providing state-of-the-art information on the most effective prevention and treatment options. Included are research articles on nutrition management and the prevention of sarcopenia; protein therapy for sarcopenia; effect of exercise

Sarcopenia – Age-Related Muscle Wasting and Weakness

Sarcopenia – Age-Related Muscle Wasting and Weakness
  • Author : Gordon S. Lynch
  • Publisher : Springer Science & Business Media
  • Release : 30 November 2010
GET THIS BOOKSarcopenia – Age-Related Muscle Wasting and Weakness

Some of the most serious consequences of aging are its effects on skeletal muscle. ‘Sarcopenia’, the progressive age-related loss of muscle mass and associated muscle weakness, renders frail elders susceptible to serious injury from sudden falls and fractures and at risk for losing their functional independence. Not surprisingly, sarcopenia is a significant public health problem throughout the developed world. There is an urgent need to better understand the neuromuscular mechanisms underlying age-related muscle wasting and to develop therapeutic strategies that

Reverse Sarcopenia

Reverse Sarcopenia
  • Author : Joseph Tieri
  • Publisher : Simon and Schuster
  • Release : 26 July 2019
GET THIS BOOKReverse Sarcopenia

Take control of your physical and brain health with low-level strength training We all know that we lose muscle mass as we age. But did you know that sarcopenic obesity (a.k.a. being “skinny fat”) is linked to increasing your risk of developing dementia and/or Alzheimer’s? Not only is losing muscle bad for your body, it’s also bad for your brain. Don’t let muscle deterioration negatively affect your future. It’s time to take your

Sarcopenia

Sarcopenia
  • Author : Kunihiro Sakuma
  • Publisher : Elsevier
  • Release : 15 July 2021
GET THIS BOOKSarcopenia

As the global population ages, sarcopenia remains a therapeutic challenge and major public health concern. Difficulties in defining sarcopenia as a clinical phenotype remain and have hindered treatment. Sarcopenia: Molecular Mechanism and Management Strategies provides answers and guidance on this disease that has serious health consequences in terms of fractures, frailty, disability, and a diminished quality of life. Written by experts around the world, this book is for all those that care of our aging population. Presents physical, dietary, and

Sarcopenia

Sarcopenia
  • Author : Dominique Meynial-Denis
  • Publisher : CRC Press
  • Release : 20 November 2019
GET THIS BOOKSarcopenia

Sarcopenia: Molecular, Cellular, and Nutritional Aspects describes the progressive loss of skeletal muscle mass and strength, defined by Rosenberg in 1997 as a hallmark of aging and referred to as “sarcopenia.” As life expectancy continues to increase worldwide, sarcopenia has become a major public health issue. The condition worsens in the presence of chronic diseases accelerating its progression. Sarcopenia is not considered to be “a process of normative aging” but according to the International Classification of Disease, Tenth Revision, Clinical Modification (

Pathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: A Translational Approach

Pathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: A Translational Approach
  • Author : Luciano Merlini,Paolo Bonaldo,Emanuele Marzetti
  • Publisher : Frontiers Media SA
  • Release : 18 January 2016
GET THIS BOOKPathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: A Translational Approach

Loss of muscle mass and increased fibrosis characterize both sarcopenia of aging and muscular dystrophy. Research is increasingly showing that these two conditions also share several pathophysiological mechanisms, including mitochondrial dysfunction, increased apoptosis, abnormal modulation of autophagy, decline in satellite cells, increased generation of reactive oxygen species, and abnormal regulation of signaling and stress response pathways. This Research Topic will cover several mechanisms involved in aging and dystrophic sarcopenia and explore the therapeutic potential of various strategies for intervention.

Frailty and Sarcopenia in Cirrhosis

Frailty and Sarcopenia in Cirrhosis
  • Author : Puneeta Tandon,Aldo J. Montano-Loza
  • Publisher : Springer Nature
  • Release : 06 November 2019
GET THIS BOOKFrailty and Sarcopenia in Cirrhosis

This book provides a concise yet comprehensive overview of frailty and sarcopenia in the cirrhotic patient. The text presents a personalized approach to identifying cirrhotic patients at risk of higher morbidity and mortality due to frailty and sarcopenia. It reviews current and novel diagnostic methods, while spotlighting treatment and management strategies for frailty and sarcopenia. The book also focuses on special issues associated with these syndromes, such as the effect of gender, age, and ethnicity on frailty and sarcopenia, sarcopenic

Sarcopenia – Age-Related Muscle Wasting and Weakness

Sarcopenia – Age-Related Muscle Wasting and Weakness
  • Author : Gordon S. Lynch
  • Publisher : Springer
  • Release : 12 November 2014
GET THIS BOOKSarcopenia – Age-Related Muscle Wasting and Weakness

Some of the most serious consequences of aging are its effects on skeletal muscle. ‘Sarcopenia’, the progressive age-related loss of muscle mass and associated muscle weakness, renders frail elders susceptible to serious injury from sudden falls and fractures and at risk for losing their functional independence. Not surprisingly, sarcopenia is a significant public health problem throughout the developed world. There is an urgent need to better understand the neuromuscular mechanisms underlying age-related muscle wasting and to develop therapeutic strategies that

Fragility Fracture Nursing

Fragility Fracture Nursing
  • Author : Karen Hertz,Julie Santy-Tomlinson
  • Publisher : Springer
  • Release : 15 June 2018
GET THIS BOOKFragility Fracture Nursing

This open access book aims to provide a comprehensive but practical overview of the knowledge required for the assessment and management of the older adult with or at risk of fragility fracture. It considers this from the perspectives of all of the settings in which this group of patients receive nursing care. Globally, a fragility fracture is estimated to occur every 3 seconds. This amounts to 25 000 fractures per day or 9 million per year. The financial costs are reported to be: 32 billion

Recent Advances of Sarcopenia and Frailty in CKD

Recent Advances of Sarcopenia and Frailty in CKD
  • Author : Akihiko Kato,Eiichiro Kanda,Yoshihiko Kanno
  • Publisher : Springer Nature
  • Release : 29 February 2020
GET THIS BOOKRecent Advances of Sarcopenia and Frailty in CKD

This book highlights recent advances in our understanding of sarcopenia and frailty in CKD. The prevalence of sarcopenia and frailty increases substantially as CKD progresses, and experimental studies have demonstrated the pivotal role of accumulated uremic toxin in the development of muscle wasting. Further, sarcopenia and frailty are associated with falls, bone fractures, cognitive impairment, and poor survival prognoses, especially in elderly CKD patients. The syndromes are also related to the risk of end-stage kidney disease. This book provides readers

Choosing the StrongPath

Choosing the StrongPath
  • Author : Fred Bartlit,Steven Droullard,Marni Boppart, ScD
  • Publisher : Greenleaf Book Group
  • Release : 02 January 2018
GET THIS BOOKChoosing the StrongPath

Choose health. Choose strength. Choose the StrongPath. Choosing the StrongPath is a book about the most insidious health crisis in the world, Sarcopenia, a muscle-wasting and frailty disease. It impacts all of us as we age, unless we proactively prevent it. As a world-renowned investigator and case builder, Fred Bartlit has done this once again with this book. He and coauthor Steven Droullard, along with muscle physiology expert Dr. Marni Boppart, want to share a little known fact with the

Assessment and Treatment of Sarcopenia and Frailty in the Setting of Personalized Internal Medicine

Assessment and Treatment of Sarcopenia and Frailty in the Setting of Personalized Internal Medicine
  • Author : Gad Segal,Amir Tirosh,Idan Goren
  • Publisher : Cambridge Scholars Publishing
  • Release : 27 January 2020
GET THIS BOOKAssessment and Treatment of Sarcopenia and Frailty in the Setting of Personalized Internal Medicine

The recognition and implementation of personalized internal medicine is of the utmost importance for physicians, nurses, dieticians and other healthcare professionals engaged in clinics. The assessment of sarcopenia and frailty, in middle-aged patients, as an embodiment of treatment personalization, is essential in settings of acute and chronic disease, both in the hospital and in ambulatory settings. This book describes various practical tools for the assessment of sarcopenia and frailty, reviews relevant findings from the current professional literature, and suggests treatment